Use of atypical antipsychotics during pregnancy and the risk of neural tube defects in infants

American Journal of Psychiatry

Volumn 159, Issue 1, 2002, Pages 136-137

  Koren, Gideon ^a   Cohn, Tony ^b   Chitayat, David ^b   Kapur, Bhushan ^b   Remington, Gary ^b   Reid, Diane Myles ^b   Zipursky, Robert B ^b  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; CLOZAPINE; FOLIC ACID; NEUROLEPTIC AGENT; OLANZAPINE; QUETIAPINE; RISPERIDONE;

ADULT; AGED; ARTICLE; BODY MASS; BODY WEIGHT; CONTROLLED STUDY; FEMALE; FOLIC ACID BLOOD LEVEL; FOLIC ACID DEFICIENCY; HOSPITAL PATIENT; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; NEURAL TUBE DEFECT; OBESITY; OUTPATIENT; PREGNANCY; PRIORITY JOURNAL; RANDOMIZATION; RISK ASSESSMENT; SAMPLE SIZE; SCHIZOPHRENIA; STATISTICAL SIGNIFICANCE; VITAMIN INTAKE; BLOOD; CHEMICALLY INDUCED DISORDER; NEWBORN; PREGNANCY COMPLICATION; RISK FACTOR;

ADULT; ANTIPSYCHOTIC AGENTS; BODY MASS INDEX; FEMALE; FOLIC ACID; HUMANS; INFANT, NEWBORN; MALE; NEURAL TUBE DEFECTS; OBESITY; PREGNANCY; PREGNANCY COMPLICATIONS; RISK FACTORS; SCHIZOPHRENIA;

EID: 0036370613     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.159.1.136     Document Type: Article

References (15)

1. Mossman D, Lehrer DS: Conventional and atypical antipsychotics and the evolving standard of care. Psychiatr Serv 2000; 51:1528-1535
2. Kapur S, Remington G: Atypical antipsychotics: patients value the lower incidence of extrapyramidal side effects. Br Med J 2000; 321:1360-1361
3. Blackburn GL: Weight gain and antipsychotic medication. J Clin Psychiatry 2000; 61(suppl 8):36-42
4. Green Al, Patel JK, Goisman RM, Allison DB, Blackburn G: Weight gain from novel antipsychotic drugs: need for action. Gen Hosp Psychiatry 2000; 22:224-235
5. Taylor DM, McAskill R: Atypical antipsychotics and weight gain - a systematic review. Acta Psychiatr Scand 2000; 101:416-432
6. Werler MM, Louik C, Shapiro S, Mitchell AA: Pre-pregnancy weight in relation to risk of neural tube defects. JAMA 1996; 275:1089-1092
7. Shaw GM, Velie EM, Schaffer D: Risk of neural tube defect-affected pregnancies among obese women. JAMA 1996; 275:1093-1096
8. Shaw GM, Todoroff K, Finnell RH, Lammer EJ: Spina bifida phenotypes in infants or fetuses of obese mothers. Teratology 2000; 61:376-381
9. National Population Health Survey Overview 1994-95. Ottawa, Ont, Statistics Canada, 1995, pp 1-17
10. Goldstein DJ, Carbin LA, Fung MC: Olanzapine-exposed pregnancies and lactation; early experience. J Clin Psychopharmacol 2000; 20:399-403
11. Stones SC, Sommi RW, Rasken PA, Anya I, Vaughn J: Clozapine use in two full-term pregnancies. J Clin Psychiatry 1997; 58:364-365
12. Mukherjee S, Decina P, Bocola V, Saraceni F, Scapicchio PL: Diabetes mellitus in schizophrenic patients. Compr Psychiatry 1996; 37:68-73
13. Dixon L, Weiden P, Delahanty J, Goldberg R, Postrado L, Lucksted A, Lehman A: Prevalence and correlates of diabetes in national schizophrenia samples. Schizophr Bull 2000; 26:903-912
14. Henderson DC, Cagliero E, Gray C, Nasrallah RS, Hayden DL, Schoenfeld DA, Goff DC: Clozapine, diabetes mellitus, weight gain, and lipid abnormalities: a five-year naturalistic study. Am J Psychiatry 2000; 157:975-981
15. Fung TT, Rimm EB, Spiegelman D, Fifai N, Tafler GH, Willett WC, Hu FB: Association between dietary patterns and plasma biomarkers of obesity and cardiovascular disease risk. Am J Clin Nutr 2001; 73:61-67